ALBERICI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 3.053
AS - Asia 2.549
EU - Europa 1.876
SA - Sud America 314
AF - Africa 57
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.890
Nazione #
US - Stati Uniti d'America 2.886
CN - Cina 1.047
SG - Singapore 576
GB - Regno Unito 399
IT - Italia 397
JP - Giappone 244
HK - Hong Kong 167
ES - Italia 163
DE - Germania 161
BR - Brasile 160
RU - Federazione Russa 149
IN - India 135
FR - Francia 116
MX - Messico 83
IE - Irlanda 80
TR - Turchia 70
CA - Canada 62
NL - Olanda 57
SE - Svezia 56
AR - Argentina 52
VN - Vietnam 50
ID - Indonesia 49
KR - Corea 45
CO - Colombia 43
PL - Polonia 41
CH - Svizzera 38
AT - Austria 34
AU - Australia 33
TW - Taiwan 24
NO - Norvegia 23
GR - Grecia 22
CL - Cile 21
IR - Iran 20
BE - Belgio 19
DK - Danimarca 19
PT - Portogallo 19
PE - Perù 18
IL - Israele 16
UA - Ucraina 16
MA - Marocco 15
MY - Malesia 15
SA - Arabia Saudita 15
RO - Romania 13
BD - Bangladesh 11
EG - Egitto 11
HU - Ungheria 11
TH - Thailandia 11
ZA - Sudafrica 11
CI - Costa d'Avorio 9
FI - Finlandia 9
RS - Serbia 9
IQ - Iraq 8
PK - Pakistan 8
VE - Venezuela 7
EC - Ecuador 6
BG - Bulgaria 5
CZ - Repubblica Ceca 5
GT - Guatemala 5
NP - Nepal 5
NZ - Nuova Zelanda 5
AE - Emirati Arabi Uniti 4
AM - Armenia 4
HR - Croazia 4
KE - Kenya 4
KW - Kuwait 4
KZ - Kazakistan 4
PS - Palestinian Territory 4
BO - Bolivia 3
CR - Costa Rica 3
EU - Europa 3
HT - Haiti 3
JO - Giordania 3
LV - Lettonia 3
PR - Porto Rico 3
SI - Slovenia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
DZ - Algeria 2
LA - Repubblica Popolare Democratica del Laos 2
NG - Nigeria 2
QA - Qatar 2
AL - Albania 1
AZ - Azerbaigian 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HN - Honduras 1
IM - Isola di Man 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MN - Mongolia 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
Totale 7.890
Città #
Singapore 312
Southend 242
Ashburn 238
Fairfield 202
Beijing 198
Redwood City 172
Dearborn 131
Chandler 122
Hong Kong 120
Santa Clara 110
Woodbridge 105
Milan 90
Seattle 90
Houston 83
Dublin 79
Cambridge 78
Guangzhou 76
Princeton 76
Council Bluffs 75
Dallas 71
Nanjing 71
Wilmington 70
Tokyo 69
Shanghai 65
Ann Arbor 63
Los Angeles 59
Phoenix 57
New York 56
Des Moines 46
Jakarta 36
San Jose 35
Bengaluru 30
Barcelona 29
Madrid 29
Hefei 27
Moscow 27
Central District 26
Mexico City 26
Shenyang 26
Columbus 25
Frankfurt am Main 25
Istanbul 25
Nanchang 25
Hangzhou 23
London 23
The Dalles 23
Buffalo 22
Florence 21
São Paulo 21
Vienna 21
Seoul 20
Zurich 20
Changsha 19
Chengdu 19
Warsaw 19
Zhengzhou 19
Buenos Aires 18
Jinan 18
Bathinda 16
Brescia 16
Delhi 16
Falls Church 16
Ho Chi Minh City 16
Wuhan 16
Chongqing 15
Mumbai 15
Paris 15
Rome 15
Tianjin 15
Bogotá 13
Brooklyn 13
Riyadh 13
Santiago 13
Chennai 12
Medellín 12
Montreal 12
Ottawa 12
Silver Spring 12
Ankara 11
Cinisello Balsamo 11
Hebei 11
New Delhi 11
Nuremberg 11
Taipei 11
Bologna 10
Chicago 10
Heidelberg 10
Rio de Janeiro 10
San Diego 10
Abidjan 9
Athens 9
Baltimore 9
Brussels 9
Duncan 9
Fuzhou 9
Lima 9
Parma 9
San Francisco 9
Toronto 9
Boston 8
Totale 4.420
Nome #
Lupus nephritis and B-cell targeting therapy 1.424
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis 973
Rituximab as maintenance treatment for systemic Lupus Erythematosus: a multicentre observational study of 147 patients 707
Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial 402
Chronic periaortitis with thoracic aorta and epiaortic artery involvement : a systemic large vessel vasculitis? 324
Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis 311
Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis 222
Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases and review of the literature 214
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 203
PTPN22 R620W polymorphism in the ANCA-associated vasculitides 181
Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis 172
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index 167
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis : a randomised trial 165
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 159
Genetics of ANCA-Associated Vasculitis 144
Update on ANCA-associated vasculitis : from biomarkers to therapy 140
Magnetic resonance imaging in central nervous system vasculitis in a patient affected by crioglobulin-negative hepatitis C virus infection: A likely correlation 137
Long Term Outcomes of Anti-COVID-19 Vaccines in Patients with Systemic Lupus Erythematosus: A Multicentre Study 129
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 126
FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome 125
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination 124
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN 118
Prevention of arterial thrombosis recurrence in anti-phospholipid syndrome: are anti-platelets the answer? 104
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 93
The role of analytical methods for the determination of trace elements in environmental biomonitors 90
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis 87
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 86
Association of a polymorphism of the Fcγ-receptor 2A (FCGR2A) gene with chronic periaortitis 86
Natural killer cell cytotoxicity is enhanced by very low doses of rIL-2 and rIFN-alpha in patients with renal cell carcinoma 82
Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC) 81
Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC) : a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC) 81
Rituximab-associated hypogammaglobulinemia : incidence, predictors and outcomes in patients with multi-system autoimmune disease 75
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial 71
Impact of rituximab trials on the treatment of ANCA-associated vasculitis 70
Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease : a case series 69
Chronic periaortitis associated with membranous nephropathy: clues to common pathogenetic mechanisms 67
Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis 65
Orofacial granulomatosis treated with low-level laser therapy: a case report 63
IgG4 immune response in Churg-Strauss syndrome 63
Genetics of ANCA-associated vasculitides: HLA and beyond 59
Chronically administered immunotherapy with low-dose IL-2 and IFN-alpha in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profile 57
Incremental peritoneal dialysis: less is more—for the patient and the planet 37
Totale 8.153
Categoria #
all - tutte 21.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.149


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021540 0 0 0 0 0 99 64 79 62 101 67 68
2021/2022711 56 53 38 62 55 52 60 51 73 59 39 113
2022/2023809 107 37 27 70 80 125 33 72 127 26 65 40
2023/2024732 52 59 35 53 146 44 42 53 42 51 64 91
2024/20251.368 57 136 45 93 182 88 66 166 85 111 132 207
2025/20261.373 227 89 217 288 389 163 0 0 0 0 0 0
Totale 8.153